Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases.
Minesh P. Mehta
Employment or Leadership Position - Pharmacyclics
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Elekta; Merck; Novartis; Quark; Tomotherapy; US Oncology; Vertex
Stock Ownership - Accuray; Colby; Pharmacyclics; ProCertus; Stemina
Honoraria - GRACE Foundation; MCM; Merck; Prime Oncology; Strategic Edge; WebMD
Walter J. Curran
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Abbott Laboratories
Ding Wang
Research Funding - Abbott Laboratories
Fen Wang
No relevant relationships to disclose
Lawrence Kleinberg
Research Funding - Abbott Laboratories
Anthony M. Brade
No relevant relationships to disclose
Nael Mostafa
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Xiangdong Zhou
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Jiang Qian
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Terri Leahy
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Bhardwaj Desai
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Vincent L. Giranda
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories